Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Canagliflozin
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus With Complication
1 trial -
Cannabis (30% THC Concentrate)
BRIGHT MINDS BIOSCIENCES INC.
THC
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Carbon ion radiotherapy
Shanghai Proton and Heavy Ion Center
Pancreatic Cancer Non-resectable
1 trial -
Cardiopulmonary Exercise Testing
Esperion Therapeutics
Intrauterine Growth Restriction
1 trial -
Carrelizumab
The First People's Hospital of Lianyungang
Cholangiocarcinoma
1 trial -
Cefazolin with Daptomycin
Hospital Authority, Hong Kong
Periprosthetic Joint Infection
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety
1 trial -
Celastrol
Nanjing Legend Biotech Co.
Safety Issues
1 trial -
Chinese herbs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Cigarette
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
1 trial -
Ciprofol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sedation
1 trial -
Citalopram
COGNITION THERAPEUTICS INC
Antidepressive Agents, Second-Generation
1 trial -
Clopidogrel
BRIGHT MINDS BIOSCIENCES INC.
Metabolism of Clopidogrel
1 trial -
Coenzyme Q10
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cardiovascular Disease
1 trial -
Cognitive behavioral therapy for anxiety plus benzodiazepine taper
BRIGHT MINDS BIOSCIENCES INC.
Anxiety Disorders
1 trial -
Colostrum supplementation for bone loss
Petros Pharmaceuticals
Osteopenia
1 trial -
Combination Product: Conventional third-line therapy
The First People's Hospital of Lianyungang
Colorectal Cancer (CRC)
1 trial -
Combination group
Hospital Authority, Hong Kong
Cardiac Arrest
1 trial -
Combination of chemotherapy and immunotherapy
The First People's Hospital of Lianyungang
Non Small Cell Lung Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Combination of targeted biopsy and systematic biopsy
Peking University Third Hospital
Prostate Cancer
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources